Modulation of histamine-induced bronchoconstriction with inhaled, oral, and intravenous clemastine in normal and asthmatic subjects.

AUTOR(ES)

Hartmann, V

RESUMO

Although histamine plays an important role in the pathophysiology of asthma through stimulation of H1 receptors, H1 antagonists are of only limited use in this disease when given orally. In order to investigate the pharmacological response to a specific H1 antagonist administered by different routes, we measured the effect of inhaled clemastine on airway responsiveness to histamine aerosol and compared the results with those after oral and intravenous administration in normal and asthmatic subjects. Inhalation of 0.6 mg clemastine provided significant protection without side effects and was comparable to intravenous administration of 1.0 mg in both groups. In normal subjects 2.0 mg clemastine orally was significantly less effective than the two other routes of administration whereas in asthmatics an enhanced reaction to histamine was observed.

Documentos Relacionados

• Analysis of tidal expiratory flow pattern in the assessment of histamine-induced bronchoconstriction.
• Refractory period following bronchoconstriction provoked by histamine in asthmatic subjects.
• The nasal response to exercise and exercise induced bronchoconstriction in normal and asthmatic subjects.
• Effects of histamine on lung permeability in normal and asthmatic subjects.
• Protective effect of drugs on histamine-induced asthma.